The Role of Genetic Polymorphisms in Antioxidant Enzymes and Potential Antioxidant Therapies in Neonatal Lung Disease
Authors:
- 1 November 2014
- journal article
- review article
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 21 (13) , 1863-1880
Abstract
Significance: Oxidative stress is involved in the development of newborn lung diseases, such as bronchopulmonary dysplasia and persistent pulmonary hypertension of the newborn. The activity of antioxidant enzymes (AOEs), which is impaired as a result of prematurity and oxidative injury, may be further affected by specific genetic polymorphisms or an unfavorable combination of more of them. Recent Advances: Genetic polymorphisms of superoxide dismutase and catalase were recently demonstrated to be protective or risk factors for the main complications of prematurity. A lot of research focused on the potential of different antioxidant strategies in the prevention and treatment of lung diseases of the newborn, providing promising results in experimental models. Critical Issues: The effect of different genetic polymorphisms on protein synthesis and activity has been poorly detailed in the newborn, hindering to derive conclusive results from the observed associations with adverse outcomes. Therapeutic strategies that aimed at enhancing the activity of AOEs were poorly studied in clinical settings and partially failed to produce clinical benefits. Future Directions: The clarification of the effects of genetic polymorphisms on the proteomics of the newborn is mandatory, as well as the assessment of a larger number of polymorphisms with a possible correlation with adverse outcome. Moreover, antioxidant treatments should be carefully translated to clinical settings, after further details on optimal doses, administration techniques, and adverse effects are provided. Finally, the study of genetic polymorphisms could help select a specific high-risk population, who may particularly benefit from targeted antioxidant strategies. Antioxid. Redox Signal. 21, 1863–1880.Keywords
This publication has 195 references indexed in Scilit:
- Apocynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newbornAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- Genetic associations of surfactant protein D and angiotensin-converting enzyme with lung disease in preterm neonatesJournal of Perinatology, 2011
- Hydrogen Peroxide Regulates Extracellular Superoxide Dismutase Activity and Expression in Neonatal Pulmonary HypertensionAntioxidants & Redox Signaling, 2011
- SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Modification of surfactant protein D by reactive oxygen‐nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivoThe FASEB Journal, 2009
- Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- EXPRESSION OF CONCERN: Superoxide from NADPH oxidase upregulates type 5 phosphodiesterase in human vascular smooth muscle cells: inhibition with iloprost and NONOateBritish Journal of Pharmacology, 2008
- Association of interferon T+874A and interleukin 12 p40 promoter CTCTAA/GC polymorphism with the need for respiratory support and perinatal complications in low birthweight neonatesArchives of Disease in Childhood - Fetal and Neonatal Edition, 2007
- A functional SNP in the promoter of the SERPINH1 gene increases risk of preterm premature rupture of membranes in African AmericansProceedings of the National Academy of Sciences, 2006
- Sod mimetics are coming of ageNature Reviews Drug Discovery, 2002